| Literature DB >> 29213585 |
Eliasz Engelhardt1, Denise Madeira Moreira1, Gilberto Oliveira Alves1, Maria Elisa Oliveira Lanna1, Carlos Eduardo de Oliveira Alves1, Letice Ericeira-Valente1, Felipe Kenji Sudo1, Jerson Laks1.
Abstract
To study the integrity of the corpus callosum in Binswanger's disease (BD) patients using quantitative fractional anisotropy (DTI-FA).Entities:
Year: 2008 PMID: 29213585 PMCID: PMC5619080 DOI: 10.1590/S1980-57642009DN20400008
Source DB: PubMed Journal: Dement Neuropsychol ISSN: 1980-5764
Characteristics of the sample.
| NC | BD | |
|---|---|---|
| N | 12 | 12 |
| sex (m/f) | 5/7 | 7/5 |
| age (range) | 74.8±5.1 | 77.6±8.6 |
| education (years: m±sd) | 12.4±2.43 | 9.67±4.56 |
| NINDS-AIREN | negative | positive |
| MMSE[ | 27.4±2.70 | 20.2±5.37 |
| CDR[ | 0 | 1.50±0.64 |
| Hachinski[ | 0.92±0.79 | 8.75±4.14 |
| Fazekas[ | 2.0±0.85 | 6.0±0.0 |
| leukoaraiosis (extension %) | -- | ≥75% |
NC, normal controls; BD, Binswanger's disease; NINDS-AIREN, National Institute of Neurological Disorders and Stroke and Association Internationale pour la Recherché et l'Enseignement en Neurosciences (criteria for clinical diagnosis of vascular dementia);
Mini Mental State Examination (short cognitive screening tool);
CDR, Clinical Dementia Rating scale (global severity stages from 0 to 3);
Hachinski, ischemic score (clinical assessment of vascular risk);
Fazekas, white matter lesion scale (severity from 0 to 6).
Figure 1MR scans in FLAIR acquisition (axial plane) – sections at basal ganglia level (a1 and b1) and at supracallosal level (a2 and b2), in normal controls and Binswanger’s disease patients, respectively. The images represent examples from the study (Table 1).
Figure 2MR scans (axial plane) - sections at basal ganglia level: (A) 3DT1 sequence and (B) DTI-FA map. 3DT1 image for topographical reference, DTI-FA map is shown to localize ROI placement.
Results of quantitative FA in NC vs BD.
| Regions | ROIs (n) | FA units (mean±sd) | |
|---|---|---|---|
| NC | BD | ||
| Genu | 12 | 0.6041±0.05 | 0.5555±0.08 |
| Splenium | 12 | 0.7230±0.04 | 0.6394±0.08 |
| Total | 24 | 0.6635±0.08 | 0.5975±0.09 |
Statistical significance as shown with ANOVA.
| ANOVA summary | |||||
|---|---|---|---|---|---|
| Source | SS | df | MS | F | p |
| Rows[ | 0.12 | 1 | 0.12 | 27.79 | <0.0001 |
| Columns[ | 0.05 | 1 | 0.05 | 11.58 | 0.0014 |
| Rows × columns | 0.01 | 1 | 0.01 | 2.32 | 0.1349 |
| Error | 0.19 | 44 | 0 | ||
| Total | 0.37 | 47 |
inter-sample (genu and splenium - NC vs BD);
intra-sample (genu vs splenium - NC and BD).
Critical values for the Tukey HSD Test.
| HSD [0.05] | HSD [0.01] | |
|---|---|---|
| Rows (2) | 0.04 | 0.05 |
| Columns (2) | 0.04 | 0.05 |
| Cells (4) | 0.07 | 0.09 |
HSD, Highest significant difference.